• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
COVID-19 Management

COVID-19 Cases in Kansas Counties That Adopted the Mask Mandate vs. Those That Opted Out

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • On June 9, 2020 the governor of Kansas enacted a state-wide mask mandate to stop the spread of COVID-19 in public spaces
    • Individual counties were able to opt out of the mandate
  • Van Dyke et al. (MMWR, 2020) report on the incidence of COVID-19 in counties with and without the state mask mandate

METHODS:

  • Data source
    • Data from the Kansas Health Institute
    • COVID case and population counts were accessed from USAFacts
  • Study design
    • Mask mandate: Counties that did not opt out
    • Opted out of mask mandate: Opted out of the state mandate, as allowed by Kansas state law, and did not adopt their own mask mandate
    • Daily county-level COVID-19 incidence: Calculated as the 7-day rolling average number of new daily cases per 100,000 population
      • Before the government order (June 1–July 2)
      • After the government order (July 3–August 23)
      • Mandated and nonmandated counties were compared over time

RESULTS:

  • Mask mandate compliance
    • Had a mask mandate: 24 counties | Accounted for 2/3 of Kansas population
    • Opted out of mask mandate: 81 counties
    • 54% mandated counties and 9% nonmandated counties had implemented at least one other public health mitigation strategy (e.g., limits on size of gatherings and occupancy for restaurants)
  • After the governor’s mask mandate, COVID-19 incidence decreased among counties with a mask mandate, but increased among counties without a mask mandate
    • Had mask mandate: Mean decrease 0.08 cases per 100,000 per day | Net decrease of 6%
    • Opted out: Mean increase 0.11 cases per 100,000 per day | Net increase of 100%

CONCLUSION:

  • Kansas counties that adopted a mask mandate decreased the incidence of COVID-19, while those counties that opted out saw a continued increase in cases, providing more evidence for the benefit of face masks for preventing the transmission of SARS-CoV-2
  • The authors state

After implementation of mask mandates in 24 Kansas counties, the increasing trend in COVID-19 incidence reversed

…rates in mandated counties declined markedly after July 3, compared with those in nonmandated counties

Kansas counties that had mask mandates in place appear to have mitigated the transmission of COVID-19, whereas counties that did not have mask mandates continued to experience increases in cases

Learn More – Primary Sources:

Trends in County-Level COVID-19 Incidence in Counties With and Without a Mask Mandate — Kansas, June 1–August 23, 2020

Get COVID-19 Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All COVID-19 Management Posts
Next >

Related ObG Topics:

Surgical Masks Reduce Viral Shedding
Universal Masking and COVID-19 Infection Rates in Healthcare Personnel
What is the Probability of a False Negative When Taking a SARS-CoV-2 Test?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site